AVOPEF vs CAMPTOSAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Possible drug interaction. AVOPEF and CAMPTOSAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AVOPEF	CAMPTOSAR
Rating	New	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ETOPOSIDE	IRINOTECAN HYDROCHLORIDE
Manufacturer	Avyxa Holdings	Pfizer
Dosage forms	Injectable	Injectable
Drug class	Topoisomerase Inhibitor	Topoisomerase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms

avopef camptosar

Rating

New

64/100

Pharmacy pays

—

Type

Active ingredient

ETOPOSIDE

IRINOTECAN HYDROCHLORIDE

Manufacturer

Avyxa Holdings

Pfizer

Dosage forms

Injectable

Drug class

Topoisomerase Inhibitor

Boxed warning

Treats

Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms

Frequently asked questions

What is the difference between Avopef and Camptosar?

Avopef contains Etoposide, while Camptosar contains Irinotecan Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.